myCardioMEMS™ 1.2.1

The myCardioMEMS™ Patient Application by Abbott is specifically designed for patients utilizing the CardioMEMS™ HF System. This application serves as a communication tool, facilitating the exchange of crucial information between patients and their healthcare providers.

Upon installation, the app transforms your smartphone into an interactive platform enabling seamless communication with your healthcare team. The user-friendly interface allows for effortless tracking of pulmonary artery (PA) pressure readings and ensures timely updates regarding your therapy.

Not only can patients download the myCardioMEMS app, but primary caregivers such as family members can also access it. Additionally, a secondary caregiver feature permits designated individuals to view the message history within the application.

Key Features:

• Track daily CardioMEMS™ PA pressure readings and receive alerts if readings have not been transmitted
• Receive medication reminders for timely intake
• Stay informed of any prescribed changes in medication dosages
• Get notifications to contact the clinic if encountering issues with medications
• Maintain a comprehensive list of heart-failure medications
• Access a history of clinic notifications and patient resources

Rx Only
Brief Summary: Prior to utilizing these devices, it is advised to review the Instructions for Use for a detailed overview of indications, contraindications, warnings, precautions, potential adverse events, and directions for usage.

Indications and Usage:
The CardioMEMS™ HF System is intended for wireless measurement and monitoring of pulmonary artery (PA) pressure and heart rate in New York Heart Association (NYHA) Class III heart failure patients with a recent history of heart failure hospitalization. This hemodynamic data aids physicians in heart failure management with the aim of reducing hospitalizations.

Contraindications:
The CardioMEMS™ HF System is contraindicated for individuals unable to take dual antiplatelet or anticoagulants post-implant.

Potential Adverse Events:
Adverse events linked to the implantation procedure comprise but are not restricted to infection, arrhythmias, bleeding, hematoma, thrombus, myocardial infarction, transient ischemic attack, stroke, death, and device embolization.

Limitations:
Users must employ their Apple‡ mobile device for information exchange with the myCardioMEMS™ mobile app. Several internal and external factors can influence the reception and delivery of notifications and patient data. These factors encompass the patient's environment, mobile device operations, clinic settings, and data processing.

™ Indicates a trademark of the Abbott group of companies.
‡ Indicates a third-party trademark owned by its respective holder.

© 2020 Abbott. All Rights Reserved.
25654-SJM-MER-1116-0092(1) | Item approved solely for use within the U.S.